FibroBiologics, Inc. Common Stock (FBLG) — Net Asset Quality Index
FibroBiologics, Inc. Common Stock (FBLG) has a Net Asset Quality Index of 1.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $8.74 Million minus total liabilities of $8.62 Million yields net assets of $125.00K. A higher index indicates a stronger, lower-leverage balance sheet. Check FibroBiologics, Inc. Common Stock cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
FibroBiologics, Inc. Common Stock Net Asset Quality Index Over Time (2022–2025)
This chart shows how FibroBiologics, Inc. Common Stock's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the index stands at 1.4%, representing net assets of $125.00K against total assets of $8.74 Million USD. See FBLG book value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for FibroBiologics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for FibroBiologics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see FBLG market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 16.6% | $2.73 Million | $16.45 Million | $13.71 Million | ▲ +6.0 pp |
| 2024 | 10.6% | $1.25 Million | $11.82 Million | $10.57 Million | ▲ +93.4 pp |
| 2023 | -82.8% | $-4.00 Million | $4.82 Million | $8.82 Million | ▲ +192.8 pp |
| 2022 | -275.6% | $-1.29 Million | $468.00K | $1.76 Million | — |